SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-014910
Filing Date
2023-05-01
Accepted
2023-05-01 13:58:51
Documents
4
Period of Report
2023-05-01

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 699371
2 formdef14a_001.jpg GRAPHIC 10885
3 formdef14a_002.jpg GRAPHIC 332204
4 formdef14a_003.jpg GRAPHIC 285854
  Complete submission text file 0001493152-23-014910.txt   1566988
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36457 | Film No.: 23872488
SIC: 2834 Pharmaceutical Preparations